Home
Site Map
Search:
About Us
Overview
Management
Collaborations & Contractors
Business Strategy
Investors
Products & Technology
Clinical Development Programs
Scientific Rationale
Intellectual property
Markets
Obesity
Antipsychotic drug induced weight gain
Newsroom
Press Releases
Media Coverage
Contact Us
About Us
Products & Technology
Markets
Newsroom
Contact Us
Development Updates
News
13.07.2010
Obecure Announces Commencement of a Follow-Up Trial to Evaluate the Safety and Efficacy of Histalean® in Mitigating Weight Gain Caused by Treatment with the Antipsychotic drug, Zyprexa®
22.02.2010
Obecure Is Granted Methods and Composition Patents Covering Adjunctive Use of Betahistine to Mitigate Weight Gain Associated With Olanzapine
©2007 All Rights Reserved to Obecure Ltd.
Disclaimer
Created by
Virtual Point Ltd.